ArticleHeliyon2024
Isorhamnetin inhibits hypertrophic scar formation through TGF-β1/Smad and TGF-β1/CREB3L1 signaling pathways.
Junzheng Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleHeliyon2024
Junzheng Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.